Home   Search   Browse   Statistics   User guide   FAQs   Post question   Download   Process data  
Search results for the GEO ID: GSE31546
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM782960
GPL570
DB3 Lung adenocarcinoma egfr status: Wild-Type gender: Female race: White adjuvant chemo: No adjuvant rx: No vital status: Alive first progression or relapse: No months to last clinical assessment: 25.2 months to last contact or death: 25.2 smoking history: Smoked in the past surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T1, ACCORDING TO AJCC CRITERIA laboratory batch: 12 histologic grade: WELL DIFFERENTIATED
GSM782961
GPL570
DB5 Lung adenocarcinoma egfr status: Wild-Type gender: Female race: Unknown adjuvant chemo: No adjuvant rx: No vital status: Alive first progression or relapse: No months to last clinical assessment: 69.2 months to last contact or death: 69.2 smoking history: Never smoked surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T1, ACCORDING TO AJCC CRITERIA laboratory batch: 12 histologic grade: WELL DIFFERENTIATED
GSM782962
GPL570
DB7 Lung adenocarcinoma egfr status: Wild-Type gender: Female race: White adjuvant chemo: No adjuvant rx: No vital status: Alive first progression or relapse: Yes months to first progression: 42.5 months to last clinical assessment: 83 months to last contact or death: 83 smoking history: Smoked in the past surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T1, ACCORDING TO AJCC CRITERIA laboratory batch: 12 histologic grade: WELL DIFFERENTIATED
GSM782963
GPL570
DB8 Lung adenocarcinoma egfr status: Wild-Type gender: Female race: White adjuvant chemo: No adjuvant rx: No vital status: Alive first progression or relapse: Yes months to first progression: 30 months to last clinical assessment: 69.2 months to last contact or death: 69.2 smoking history: Smoked in the past surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T1, ACCORDING TO AJCC CRITERIA laboratory batch: 12 histologic grade: WELL DIFFERENTIATED
GSM782964
GPL570
DB10 Lung adenocarcinoma egfr status: Wild-Type gender: Female race: White adjuvant chemo: No adjuvant rx: No vital status: Alive first progression or relapse: Yes months to first progression: 3 months to last clinical assessment: 27.1 months to last contact or death: 27.1 smoking history: Smoked in the past surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T1, ACCORDING TO AJCC CRITERIA laboratory batch: 12 histologic grade: WELL DIFFERENTIATED
GSM782965
GPL570
DB17 Lung adenocarcinoma egfr status: Mutant gender: Female race: Asian adjuvant chemo: Yes adjuvant rx: Yes vital status: Alive first progression or relapse: Yes months to first progression: 9 months to last clinical assessment: 66.6 months to last contact or death: 66.6 smoking history: Never smoked surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T2, ACCORDING TO AJCC CRITERIA laboratory batch: 13 histologic grade: Moderate Differentiation
GSM782966
GPL570
DB22 Lung adenocarcinoma egfr status: Mutant gender: Female race: White adjuvant chemo: No adjuvant rx: No vital status: Dead first progression or relapse: Yes months to last clinical assessment: 128.8 months to last contact or death: 128.8 smoking history: Smoked in the past surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T1, ACCORDING TO AJCC CRITERIA laboratory batch: 14 histologic grade: Moderate Differentiation
GSM782967
GPL570
DB35 Lung adenocarcinoma egfr status: Wild-Type gender: Male race: White adjuvant chemo: No adjuvant rx: No vital status: Alive first progression or relapse: No months to last clinical assessment: 62 months to last contact or death: 62 smoking history: Smoked in the past surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T2, ACCORDING TO AJCC CRITERIA laboratory batch: 15 histologic grade: Moderate Differentiation
GSM782968
GPL570
DB45 Lung adenocarcinoma egfr status: Mutant gender: Female race: White adjuvant chemo: No adjuvant rx: No vital status: Alive first progression or relapse: No months to last clinical assessment: 52.1 months to last contact or death: 52.1 smoking history: Smoked in the past surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T1, ACCORDING TO AJCC CRITERIA laboratory batch: 16 histologic grade: WELL DIFFERENTIATED
GSM782969
GPL570
DB48 Lung adenocarcinoma egfr status: Mutant gender: Female race: White adjuvant chemo: No adjuvant rx: No vital status: Alive first progression or relapse: No months to last clinical assessment: 86.8 months to last contact or death: 86.8 smoking history: Smoked in the past surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T1, ACCORDING TO AJCC CRITERIA laboratory batch: 16 histologic grade: WELL DIFFERENTIATED
GSM782970
GPL570
DB49 Lung adenocarcinoma egfr status: Mutant gender: Male race: Unknown adjuvant chemo: No adjuvant rx: No vital status: Alive first progression or relapse: Yes months to first progression: 102 months to last clinical assessment: 103.4 months to last contact or death: 103.4 smoking history: Smoked in the past surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T2, ACCORDING TO AJCC CRITERIA laboratory batch: 16 histologic grade: Moderate Differentiation
GSM782971
GPL570
DB56 Lung adenocarcinoma egfr status: Wild-Type gender: Female race: White adjuvant chemo: No adjuvant rx: No vital status: Alive first progression or relapse: No months to last clinical assessment: 162.6 months to last contact or death: 162.6 smoking history: Smoked in the past surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T1, ACCORDING TO AJCC CRITERIA laboratory batch: 16 histologic grade: WELL DIFFERENTIATED
GSM782972
GPL570
DB68 Lung adenocarcinoma egfr status: Wild-Type gender: Male race: White adjuvant chemo: No adjuvant rx: No vital status: Alive first progression or relapse: No months to last clinical assessment: 101.2 months to last contact or death: 101.2 smoking history: Smoked in the past surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T2, ACCORDING TO AJCC CRITERIA laboratory batch: 17 histologic grade: Moderate Differentiation
GSM782973
GPL570
DB80 Lung adenocarcinoma egfr status: Mutant gender: Female race: Not Reported adjuvant chemo: Yes adjuvant rx: Yes vital status: Alive first progression or relapse: No months to last clinical assessment: 32.9 months to last contact or death: 32.9 smoking history: Never smoked surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N1, ACCORDING TO AJCC CRITERIA pathologic t stage: T2, ACCORDING TO AJCC CRITERIA laboratory batch: 18 histologic grade: Moderate Differentiation
GSM782974
GPL570
DB82 Lung adenocarcinoma egfr status: Mutant gender: Female race: Not Reported adjuvant chemo: Yes adjuvant rx: Yes vital status: Dead first progression or relapse: Yes months to first progression: 27 months to last clinical assessment: 54.2 months to last contact or death: 54.2 smoking history: Never smoked surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T1, ACCORDING TO AJCC CRITERIA laboratory batch: 18 histologic grade: Moderate Differentiation
GSM782975
GPL570
DB84 Lung adenocarcinoma egfr status: Mutant gender: Female race: White adjuvant chemo: No adjuvant rx: No vital status: Alive first progression or relapse: Yes months to first progression: 10 months to last clinical assessment: 53.2 months to last contact or death: 53.2 smoking history: Smoked in the past surgical margins: ALL MARGINS PATHOLOGICALLY NEGATIVE pathologic n stage: N0, ACCORDING TO AJCC CRITERIA pathologic t stage: T1, ACCORDING TO AJCC CRITERIA laboratory batch: 18 histologic grade: Moderate Differentiation
GSM782976
GPL570
DB94 Lung adenocarcinoma egfr status: Wild-Type gender: Female Sex: F
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes